Moving oral solid dosage forms into the clinic quickly requires more than speed. It requires a structured approach that supports flexibility, decision-making, and long-term success. Join Bend Bioscience to explore how biopharmaceutics modeling, formulation, analytical, manufacturing, and quality strategies can accelerate Phase I readiness, reduce rework, and build a stronger foundation for later-stage development. Click here to learn more.
Integrated development and manufacturing strategies accelerate small molecule programs by reducing handoffs, streamlining clinical decision-making, enabling adaptive formulation changes, and shortening timelines through coordinated execution.
View our approach to accelerate early-phase development through streamlined first-human-dose readiness, as well as its integrated partner network for targeted protein degraders.
Discover how integrated formulation development, scalable manufacturing, and robust facility infrastructure can streamline your small molecule programs from early development through commercial production with confidence.
Get an overview of our AI-assisted early phase toolkit, which combines predictive modeling, formulation screening, and data-driven insights to accelerate molecule progression.
Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.
We support small molecule API synthesis projects from milligram to commercial quantities. We are the partner to address the most difficult challenges, whether the target is difficult to handle, synthesize, or source.
We aid with discovery, preclinical, clinical and commercial programs for New Chemical Entities (NCEs). Review our network's drug product capabilities below and contact us to simplify your outsourcing solutions.
Learn more about UK-CDMO, Upperton Pharma Solutions, and their expertise across oral, nasal, pulmonary and sterile drug product development and manufacturing
Maintain cell integrity and reliable results with ready-to-use, preservative-free solutions designed to prevent contamination and support consistent fluid quality in sensitive workflows.
Spray drying turns liquids into uniform powders, improving stability, solubility, flowability, and bioavailability while allowing precise control of particle traits.
Small molecule drugs are chemical compounds that have a low molecular weight. Due to their small size and chemical characteristics, small molecule drugs are well-suited to enter the gastrointestinal tract and quickly absorb into the bloodstream.
Explore how a data‑driven discovery model combines DEL screening, computational insights, and medicinal chemistry to accelerate decisions, reduce risk, and enable progression.
Discover versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.
